Ohlmann, Carsten-Henning http://orcid.org/0000-0003-1562-5364
Jäschke, Michelle
Jaehnig, Peter
Krege, Susanne
Gschwend, Jürgen
Rexer, Heidrun
Junker, Kerstin
Zillmann, Roger
Rüssel, Christoph
Hellmis, Eva
Suttmann, Henrik
Janssen, Martin
Marin, Jan
Hübner, Andreas
Mathers, Michael
Gleißner, Jochen
Scheffler, Michael
Feyerabend, Susan
Telle, Jens
Klier, Jörg
Stöckle, Michael
Article History
Received: 4 February 2022
Revised: 6 March 2022
Accepted: 24 March 2022
First Online: 16 April 2022
Change Date: 20 July 2022
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Change Date: 30 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-023-00682-2
Competing interests
: The authors declare no conflicts of interests other than the financial support of the trial by Janssen-Cilag GmbH, Germany.
: This study was conducted in accordance with the Declaration of Helsinki approved by the trial-leading Ethics Committee of the Saarland (reference number 143/13) and the Ethics Committees of each trial site. All patients gave written informed consent prior to participation in the trial.